Index - P/E - EPS (ttm) -18.63 Insider Own 1.17% Shs Outstand 45.71M Perf Week -3.86%
Market Cap 2.34B Forward P/E 11.17 EPS next Y 4.59 Insider Trans 0.00% Shs Float 45.17M Perf Month -4.81%
Enterprise Value 3.55B PEG - EPS next Q 1.28 Inst Own 96.83% Short Float 3.53% Perf Quarter 2.11%
Income -859.00M P/S 1.25 EPS this Y -18.22% Inst Trans 2.49% Short Ratio 3.03 Perf Half Y -10.51%
Sales 1.87B P/B 1.24 EPS next Y 26.10% ROA -16.13% Short Interest 1.60M Perf YTD -28.27%
Book/sh 41.33 P/C 8.55 EPS next 5Y 5.90% ROE -34.43% 52W High 89.09 -42.46% Perf Year -39.81%
Cash/sh 5.99 P/FCF 32.54 EPS past 3/5Y -2.58% -15.86% ROIC -25.60% 52W Low 45.21 13.38% Perf 3Y -49.85%
Dividend Est. 1.65 (3.21%) EV/EBITDA 9.45 Sales past 3/5Y 0.03% -3.25% Gross Margin 23.97% Volatility 2.63% 2.35% Perf 5Y -30.91%
Dividend TTM 1.64 (3.20%) EV/Sales 1.90 EPS Y/Y TTM -690.99% Oper. Margin 4.44% ATR (14) 1.41 Perf 10Y 0.29%
Dividend Ex-Date Aug 29, 2025 Quick Ratio 1.33 Sales Y/Y TTM -11.38% Profit Margin -45.96% RSI (14) 38.93 Recom 1.83
Dividend Gr. 3/5Y 11.17% 8.52%Current Ratio 2.68 EPS Q/Q -5976.28% SMA20 -5.93% Beta 0.50 Target Price 64.73
Payout 46.75% Debt/Eq 0.79 Sales Q/Q -14.89% SMA50 -3.57% Rel Volume 0.85 Prev Close 51.69
Employees 3200 LT Debt/Eq 0.78 Earnings Jul 29 AMC SMA200 -11.90% Avg Volume 526.11K Price 51.26
IPO May 08, 1950 Option/Short Yes / Yes EPS/Sales Surpr. -13.69% -2.85% Trades
Volume 448,608 Change -0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-08-25 Initiated Morgan Stanley
Equal-Weight
$60
May-01-25 Downgrade Wells Fargo
Overweight → Equal Weight
Mar-26-25 Upgrade JP Morgan
Neutral → Overweight
$68 → $71
Mar-05-25 Downgrade Seaport Research Partners
Buy → Neutral
Aug-08-24 Upgrade JP Morgan
Underweight → Neutral
$90 → $89
Apr-11-24 Upgrade Wells Fargo
Equal Weight → Overweight
$100 → $112
Mar-14-24 Upgrade Jefferies
Hold → Buy
$100 → $126
Mar-01-24 Initiated Wolfe Research
Outperform
$108
Jun-29-23 Downgrade Evercore ISI
Outperform → In-line
Jun-26-23 Downgrade BMO Capital Markets
Outperform → Market Perform
$109 → $90
Feb-02-23 Downgrade JP Morgan
Neutral → Underweight
$104 → $105
Sep-12-22 Initiated Credit Suisse
Outperform
$120
Jan-20-22 Downgrade Wells Fargo
Overweight → Equal Weight
$120 → $110
Nov-11-21 Downgrade Monness Crespi & Hardt
Buy → Neutral
Oct-13-21 Initiated Mizuho
Buy
$116
Jul-30-21 Upgrade JP Morgan
Underweight → Neutral
$90
Jun-18-21 Initiated Stifel
Buy
$118
May-04-21 Downgrade JP Morgan
Neutral → Underweight
$88 → $89
Mar-15-21 Resumed Credit Suisse
Outperform
$103
Feb-05-21 Reiterated Monness Crespi & Hardt
Buy
$88 → $100
Show Previous Ratings
Sep-12-25 08:19AM
06:10AM
Aug-28-25 11:30AM
Aug-12-25 05:30PM
08:56AM
05:01PM
Loading…
Aug-08-25 05:01PM
Aug-05-25 08:18AM
Jul-31-25 03:25AM
Jul-29-25 07:00PM
06:15PM
05:11PM
(Associated Press Finance)
05:01PM
09:41AM
Jul-28-25 09:27AM
Jul-23-25 10:00AM
10:00AM
Loading…
Jul-22-25 10:00AM
Jul-21-25 05:00PM
Jul-16-25 05:00PM
Jul-14-25 05:00PM
Jul-09-25 09:29AM
Jul-08-25 05:00PM
Jun-05-25 09:05AM
May-30-25 11:31AM
May-28-25 05:00PM
May-14-25 01:37PM
May-08-25 06:45AM
May-06-25 05:15PM
08:49AM
May-05-25 05:00PM
May-02-25 03:12AM
02:54AM
Loading…
02:54AM
(Thomson Reuters StreetEvents)
May-01-25 07:48PM
Apr-30-25 07:30PM
06:50PM
05:47PM
(Associated Press Finance)
05:01PM
Apr-24-25 10:01AM
08:15AM
Apr-23-25 10:01AM
Apr-22-25 11:02AM
Apr-17-25 11:16PM
06:30AM
Apr-11-25 10:07AM
Apr-10-25 09:02AM
05:50AM
Apr-03-25 12:04PM
Apr-01-25 06:59AM
Mar-28-25 05:03PM
06:59AM
Mar-26-25 10:21PM
Mar-17-25 07:00AM
Mar-13-25 02:41PM
Feb-22-25 10:04AM
Feb-13-25 08:14AM
Jan-31-25 02:17AM
Jan-30-25 03:10AM
(Thomson Reuters StreetEvents)
Jan-28-25 05:23PM
(Associated Press Finance)
-9.82%
05:01PM
07:08AM
Jan-27-25 07:04AM
Jan-20-25 05:00PM
01:09PM
Jan-16-25 07:09AM
Jan-14-25 07:00AM
Dec-23-24 05:01PM
Dec-16-24 04:15PM
Dec-09-24 05:01PM
06:30AM
Nov-21-24 01:00AM
Nov-14-24 07:00AM
Nov-08-24 07:00AM
02:16AM
Nov-06-24 07:15PM
06:27PM
(Associated Press Finance)
05:00PM
07:09AM
Nov-05-24 09:15AM
07:40AM
Oct-31-24 12:22PM
Oct-28-24 05:00PM
Oct-09-24 10:40AM
Oct-07-24 07:31AM
Sep-19-24 10:06AM
Sep-16-24 07:00AM
Sep-03-24 07:00AM
07:00AM
07:00AM
Sep-01-24 10:04PM
Aug-28-24 08:04PM
Aug-25-24 01:53PM
(The Wall Street Journal)
Aug-23-24 09:40AM
Aug-09-24 05:01PM
Aug-07-24 09:40AM
06:55AM
Aug-06-24 05:31PM
(Associated Press Finance)
05:01PM
Aug-05-24 09:40AM
Jul-25-24 04:39PM
Jul-17-24 07:00AM
Jun-24-24 07:00AM
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Assis Alessandra Faccin SVP and GM, Life Sciences Jul 25 '25 Option Exercise 51.26 3,123 160,085 6,273 Jul 28 04:30 PM MINICUCCI JAMES P. SVP and GM, Personal Care May 08 '25 Option Exercise 49.99 1,395 69,736 3,149 May 12 04:30 PM Kulkarni Ashish K Director May 06 '25 Option Exercise 0.00 1,032 0 1,032 May 08 04:30 PM NOVO GUILLERMO Chair of the Board and CEO Jan 31 '25 Buy 64.24 31,294 2,010,327 31,294 Feb 03 04:30 PM Assis Alessandra Faccin SVP and GM, Life Sciences Jan 31 '25 Buy 64.00 3,150 201,600 3,150 Feb 03 04:30 PM Harrison Suzan F. Director Jan 23 '25 Option Exercise 0.00 1,931 0 1,931 Jan 24 04:30 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Dec 05 '24 Sale 78.07 451 35,210 14,182 Dec 09 05:15 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Dec 04 '24 Option Exercise 59.95 451 27,037 14,633 Dec 05 05:00 PM BONI ERIC N Officer Dec 05 '24 Proposed Sale 78.07 451 35,210 Dec 05 09:53 AM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 19 '24 Option Exercise 76.39 418 31,931 3,641 Nov 20 04:30 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 19 '24 Sale 75.54 162 12,237 3,354 Nov 20 04:30 PM MUSA OSAMA M SVP and CTO Nov 19 '24 Option Exercise 76.39 1,878 143,460 27,288 Nov 20 04:30 PM BOSTAPH KARL R. Senior VP Operations Nov 19 '24 Option Exercise 76.39 418 31,931 7,165 Nov 20 04:30 PM Drury Eileen SVP and Chief HRO Nov 19 '24 Option Exercise 76.39 911 69,591 6,606 Nov 20 04:30 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 19 '24 Option Exercise 76.39 450 34,376 14,312 Nov 20 04:30 PM WILLIS J KEVIN SVP and CFO Nov 19 '24 Option Exercise 76.39 3,486 266,296 234,324 Nov 20 04:30 PM NOVO GUILLERMO Chair of the Board and CEO Nov 19 '24 Option Exercise 76.39 11,096 847,623 131,382 Nov 20 04:30 PM WILLIS J KEVIN SVP and CFO Nov 18 '24 Option Exercise 77.03 3,860 297,336 231,649 Nov 19 05:06 PM NOVO GUILLERMO Chair of the Board and CEO Nov 18 '24 Option Exercise 77.03 12,639 973,582 122,778 Nov 19 04:42 PM Drury Eileen SVP and Chief HRO Nov 18 '24 Option Exercise 77.03 1,101 84,810 5,956 Nov 19 04:42 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 18 '24 Option Exercise 77.03 486 37,437 3,293 Nov 19 04:41 PM MUSA OSAMA M SVP and CTO Nov 18 '24 Option Exercise 77.03 2,081 160,299 25,751 Nov 19 04:41 PM BOSTAPH KARL R. Senior VP Operations Nov 18 '24 Option Exercise 77.03 638 49,145 6,888 Nov 19 04:40 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 18 '24 Option Exercise 77.03 510 39,285 13,931 Nov 19 04:39 PM LAMPKIN ROBIN E. Officer Nov 19 '24 Proposed Sale 75.54 162 12,237 Nov 19 10:12 AM MUSA OSAMA M SVP and CTO Nov 14 '24 Option Exercise 78.05 2,031 158,520 24,776 Nov 18 05:36 PM BOSTAPH KARL R. Senior VP Operations Nov 14 '24 Option Exercise 78.05 1,054 82,265 6,728 Nov 18 05:35 PM Drury Eileen SVP and Chief HRO Nov 14 '24 Option Exercise 78.05 1,258 98,187 5,711 Nov 18 05:34 PM WILLIS J KEVIN SVP and CFO Nov 14 '24 Option Exercise 78.05 3,771 294,327 230,497 Nov 18 05:34 PM NOVO GUILLERMO Chair of the Board and CEO Nov 14 '24 Option Exercise 78.05 8,865 691,913 116,649 Nov 18 05:33 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 14 '24 Option Exercise 78.05 1,238 96,626 4,121 Nov 18 05:33 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 15 '24 Sale 77.90 868 67,617 2,883 Nov 18 05:33 PM MINICUCCI JAMES P. SVP and GM, Personal Care Nov 14 '24 Option Exercise 78.05 1,190 92,880 2,126 Nov 18 05:32 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 14 '24 Option Exercise 78.05 602 46,986 13,674 Nov 18 05:31 PM LAMPKIN ROBIN E. Officer Nov 15 '24 Proposed Sale 77.90 868 67,617 Nov 15 01:19 PM
